SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Harold Engstrom who wrote (10727)2/29/2004 11:56:02 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 52153
 
Don't know anything about it, sorry. (eom)



To: Harold Engstrom who wrote (10727)3/1/2004 10:39:32 AM
From: Biomaven  Read Replies (1) | Respond to of 52153
 
SEP225382 for migraines

I follow the migraine drug space very closely indeed (out of personal need as well as investment interest).

I'm not sure they've said anything at all about this candidate other than its name. Way back if I recall correctly they were looking at the "other" isomer of Prozac for migraine prophylaxis, but I think they abandoned this.

Peter


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News